MindWalk Holdings Corp.
HYFT · XNASCIK 1715925fmd_1XTRV7P2P69YFZ6ZNKPR7M4PRYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: May 01, 2019 to Apr 30, 2026, 18 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 14 | 18 | 19 | 21 | 25 | 25 |
| Cost of revenue | 6 | 6 | 8 | 9 | 12 | 11 |
| Gross profit | 8 | 12 | 11 | 12 | 12 | 14 |
| Research and development | 0 | 2 | 8 | 14 | 4 | 5 |
| Selling, general and administrative | – | – | 18 | 19 | 19 | 19 |
| Interest expense | 0 | 1 | 1 | 1 | 0 | 0 |
| Income before taxes | (5) | (6) | (16) | (28) | (29) | (34) |
| Income tax expense | (0) | 1 | 1 | (1) | (3) | (4) |
| Net income from continuing operations | (5) | (6) | (16) | (28) | (29) | (34) |
| Net income | (5) | (7) | (17) | (27) | (26) | (30) |